Diagnosis & Treatment
ECANA provides trusted information to help individuals understand endometrial cancer diagnosis and treatment options and make informed decisions about their care.
What Is Endometrial Cancer?
Endometrial cancer begins in the endometrium — the inner lining of the uterus — when cells in that tissue begin to grow abnormally and out of control. It's the most common cancer of the female reproductive system, and Black women are not only diagnosed at rising rates but are also disproportionately affected by more aggressive forms of the disease, including uterine papillary serous cancer. Understanding your diagnosis — what stage and grade mean, how the disease is identified, and what treatment paths exist — is one of the most powerful tools you and your care team have.
Black women are diagnosed with endometrial cancer at rates that keep rising — and are disproportionately affected by more aggressive forms, including uterine papillary serous cancer.
Warning Signs of Endometrial Cancer
Endometrial cancer is one of the more treatable cancers when caught early — and it often gives clear warning signs. Knowing what to watch for, and not dismissing symptoms, can make a real difference in outcomes.
Common Symptoms
- Abnormal vaginal bleeding, especially after menopause
- Bleeding between periods or unusually heavy periods
- Watery or blood-tinged vaginal discharge
- Pelvic pain or pressure
- Pain during urination or intercourse
- Unexplained weight loss
Why It Matters for Black Women
- Black women are more likely to be diagnosed at a later stage
- Symptoms are sometimes dismissed or attributed to fibroids without further workup
- Black women face higher rates of aggressive subtypes, including uterine papillary serous cancer
- Any postmenopausal bleeding should always be evaluated — it is never "normal"
If you experience abnormal bleeding — especially after menopause — don't wait it out. Bring it to a doctor and ask directly whether it should be evaluated for endometrial cancer.
Understanding Endometrial Cancer Stages
Staging describes how far the cancer has spread at diagnosis, and plays a major role in determining treatment.
Stage 1
Cancer is only in the uterus.
Stage 2
Cancer has spread to the cervix.
Stage 3
Cancer has spread to lymph nodes or abdominal areas.
Stage 4
Cancer has spread to the lungs or other organs.
Understanding Endometrial Cancer Grades
Grade scores how aggressive the cancer cells look under a microscope — a different measure than stage, but just as important for treatment decisions.
Grade 1 — Low
Behaves more like normal tissue, generally slower growing.
Grade 2 — Intermediate
A middle ground between low and high grade.
Grade 3 — High
Looks very different from normal tissue, tends to grow and spread faster.
This page covers the essentials — for a full breakdown of medical terms and procedures, visit our Glossary.
How Endometrial Cancer Is Diagnosed and Treated
How It's Diagnosed
- Starts with a pelvic exam and imaging
- Confirmed with a tissue sample — biopsy, D&C, or hysteroscopy
- Stage, grade, and histology guide next steps
How It's Treated
- Hysterectomy is often the first step
- Chemotherapy, radiation, or hormonal therapy — alone or combined
- Clinical trials can offer access to newer treatment combinations
Common Questions From Patients
Most cases are not directly inherited, but a family history of endometrial or colon cancer (particularly Lynch syndrome) can raise risk. If you have a strong family history, ask your doctor whether genetic counseling makes sense for you.
It depends on the stage, grade, and treatment plan. Some early-stage cases may allow for fertility-sparing options. This is an important conversation to have with your care team before treatment begins, not after.
Your care team will set a follow-up schedule with exams and, when needed, imaging or bloodwork. Recurrence risk and monitoring frequency depend on your original stage and grade — ask your doctor what your specific follow-up plan will be.
No. Trials exist at every stage, from newly diagnosed to recurrent disease. They're a treatment option worth asking about regardless of where you are in your journey.
You don't have to go through this alone. Ask your care team for a referral to a social worker or patient navigator, and look for local or online support groups specifically for gynecologic cancer survivors.
Knowledge is Power
While Black women face a 5-year survival rate of 62% for endometrial cancer compared to 84% for White women—and are twice as likely to die from the disease—Black Americans account for roughly 5% of cancer clinical trial participants nationwide. Broad representation ensures treatments are safe, effective, and tailored to everyone, making participation a critical driver for equal healthcare outcomes.
New and Emerging Research
Endometrial cancer research is active right now, across several different approaches. Current research spans several directions: treatments that help your own immune system recognize and fight cancer cells, therapies that target specific features of a tumor rather than treating the whole body, and combinations of approaches used together for advanced or recurrent disease. Some trials are also looking at ways to reduce side effects and improve quality of life during treatment.
We won't point you to one company, drug, or product — that's not our role. This page is educational only, so you can go into conversations with your care team with informed questions about whether a trial might be right for you.
Understanding Informed Consent
Informed consent is one of the most important parts of participating in a clinical trial. It's a process that ensures you have the information you need to make your own decision about whether to take part. The informed consent form (ICF) is a document given to potential participants that covers the purpose and objectives of the study, the procedures involved, the potential risks and benefits, and any foreseeable side effects.
For cancer patients, the information in an ICF can be overwhelming — these studies are often complex and may use investigational drugs or regimens not yet approved by the FDA. Clear communication with the healthcare professionals running the trial matters. Never be afraid to ask questions or ask for clarification. No one should feel pressured to agree to participate; you can take the ICF home, think it over, or talk it through with loved ones before deciding.
Representation matters. Minority participation in clinical trials is a crucial step toward reducing disparities and achieving equitable healthcare outcomes. By being informed about clinical trials, you can take part in research that directly impacts your community, addresses the health concerns you and people like you actually face, and offers access to cutting-edge treatment.
You deserve clear, reliable, and honest information when making decisions about your health. The data highlighted on this page is drawn from leading oncology researchers and national health databases:
This page is for general patient education. It does not endorse any specific treatment, product, or organization. ECANA is committed to our patients first — always. Talk with your care team about whether a clinical trial may be right for you.
Explore All Recruiting Trials Near You
Click any state to see the full range of recruiting endometrial cancer trials there, powered by ClinicalTrials.gov.